Site notifications

Sub menu

 

 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

1129 result(s) found, displaying 451 to 475

  • AusPAR: Olaparib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Olaparib

  • AusPAR: Blinatumomab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Blinatumomab

  • AusPAR: Tofacitinib (as citrate)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Tofacitinib (as citrate)

  • AusPAR: Certolizumab pegol

    Australian public assessment report (AusPar)
    Australian Public Assessment for Certolizumab pegol

  • AusPAR: Tildrakizumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Tildrakizumab

  • AusPAR: Galcanezumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Galcanezumab

  • AusPAR: Crisaborole

    Australian public assessment report (AusPar)
    Australian public assessment report for Crisaborole

  • AusPAR: Rituximab

    Australian public assessment report (AusPar)
    Australian Public Assessment for Rituximab

  • AusPAR: Dasatinib

    Australian public assessment report (AusPar)
    Australian Public Assessment for Dasatinib

  • AusPAR: Osimertinib mesilate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Osimertinib mesilate

  • AusPAR: Erenumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Erenumab

  • AusPAR: Tiotropium bromide

    Australian public assessment report (AusPar)
    Australian public assessment report for Tiotropium bromide

  • AusPAR: Inotuzumab ozogamicin

    Australian public assessment report (AusPar)
    Australian Public Assessment for Inotuzumab ozogamicin

  • AusPAR: Denosumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Denosumab

  • AusPAR: Pegfilgrastim

    Australian public assessment report (AusPar)
    Australian Public Assessment for Pegfilgrastim

  • AusPAR: Liraglutide

    Australian public assessment report (AusPar)
    Australian Public Assessment for Liraglutide

  • AusPAR: Baricitinib

    Australian public assessment report (AusPar)
    Australian Public Assessment for Baricitinib

  • AusPAR: Plitidepsin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Plitidepsin

  • AusPAR: Lenalidomide

    Australian public assessment report (AusPar)
    Australian Public Assessment for Lenalidomide

  • AusPAR: Octocog alfa (bhk)

    Australian public assessment report (AusPar)
    Australian Public Assessment for Octocog alfa (bhk)